Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial (UMA)

This study has been withdrawn prior to enrollment.
(faillure to obtain insurance because of refusal from insurance companies)
Sponsor:
Collaborators:
Gilead Sciences
Merck Sharp & Dohme Corp.
GlaxoSmithKline
Abbott
Information provided by (Responsible Party):
French National Agency for Research on AIDS and Viral Hepatitis
ClinicalTrials.gov Identifier:
NCT00936195
First received: July 8, 2009
Last updated: February 14, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)